Journal of Vascular Nursing
Volume 24, Issue 3 , Pages 91-93 , September 2006

Deep venous thrombosis recommendations

References 

  1. Ansell J , Hirsh J , Poller L , Bussey H , Jacobson A , Hylek E . The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest . 2004;126(3):204s–233s
  2. Aldrich D , Hunt DP . When can the patient with deep vein thrombosis begin to ambulate? . Phys Ther . 2004;84(3):268–273
  3. Buller HR , Sohne M , Middledorp S . Treatment of venous thromboembolism . J Thromb Haemost . 2005;3(8):1554–1560
  4. Buller HR , Agnelli G , Hull RD , Hyers TM , Prins MH , Raskob GE . Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest . 2004;126(3):401s–428s
  5. Crowther M , McCourt K . Venous thromboembolism: a guide to prevention and treatment . Nurse Pract . 2005;30(8):26–29 32-4, 39-43
  6. Federman DG , Brescia GR , Moriarty JP , Haskell SG , Krishnamurthy R , Kirsner RS . Update in thrombosis: answers to perplexing questions . Cleve Clin J Med . 2005;72(10):907–915
  7. Hirsh J , Raschke R . Heparin and low-molecular weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest . 2004;126(3): 188s–203
  8. Kearon C . Long-term management of patients after venous thromboembolism . Circulation . 2004;110(9 Suppl 1):I10–I18
  9. Nutescu EA . Emerging options in the treatment of venous thromboembolism . Am J Health Syst Pharm . 2004;61(23 Suppl 7): s12–s7
  10. Weitz JI , Hirsh J , Samama MM . New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest . 2004;126(3):265s–286s

PII: S1062-0303(06)00065-3

doi: 10.1016/j.jvn.2006.06.013

Journal of Vascular Nursing
Volume 24, Issue 3 , Pages 91-93 , September 2006

Article Tools